000 01525 a2200445 4500
005 20250517144614.0
264 0 _c20170508
008 201705s 0 0 eng d
022 _a1791-2431
024 7 _a10.3892/or.2017.5515
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQiu, Ming-Ke
245 0 0 _aROCK inhibition as a potential therapeutic target involved in apoptosis in hemangioma.
_h[electronic resource]
260 _bOncology reports
_cMay 2017
300 _a2987-2993 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmides
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aApoptosis
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHemangioma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aProliferating Cell Nuclear Antigen
_xmetabolism
650 0 4 _aPyridines
_xadministration & dosage
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
650 0 4 _aVascular Endothelial Growth Factor A
_xmetabolism
650 0 4 _arho-Associated Kinases
_xmetabolism
700 1 _aWang, Shu-Qing
700 1 _aPan, Chang
700 1 _aWang, Yang
700 1 _aQuan, Zhi-Wei
700 1 _aLiu, Ying-Bin
700 1 _aOu, Jing-Min
773 0 _tOncology reports
_gvol. 37
_gno. 5
_gp. 2987-2993
856 4 0 _uhttps://doi.org/10.3892/or.2017.5515
_zAvailable from publisher's website
999 _c27012290
_d27012290